DermatologyTier 2Disease (DEADMAN)

Cutaneous manifestations of adverse effects of therapeutic interventions - anticoagulant-related skin necrosis

Description

Anticoagulant-related skin necrosis - a rare but serious complication, classically of warfarin initiation, from a transient procoagulant state causing thrombosis in small dermal/subcutaneous vessels - see complications of therapeutic interventions for the full mechanism and prevention detail

Epidemiology

Occurs in the first few days of warfarin therapy, particularly in patients with an underlying (sometimes previously unrecognised) protein C or S deficiency

Aetiopathogenesis

Warfarin inhibits the vitamin K-dependent natural anticoagulant protein C faster than it inhibits the procoagulant factors (II, IX, X) in the first days of treatment, creating a transient hypercoagulable window - in a susceptible patient (protein C/S deficiency), this causes microvascular thrombosis in the dermis/subcutis of fatty tissue-rich areas

Diagnosis

Painful, well-demarcated purpuric lesions progressing to frank necrosis, classically in fatty tissue areas (breast, thigh, buttock, abdomen), appearing within the first ~3-10 days of warfarin initiation
Clinical diagnosis in the correct temporal context; skin biopsy if needed shows dermal vessel thrombosis without vasculitis

Management

Stop warfarin immediately, reverse with vitamin K, and continue anticoagulation with an alternative agent (heparin/LMWH) if ongoing anticoagulation is needed
Prevention: always overlap warfarin initiation with a therapeutic dose of heparin/LMWH until the INR is therapeutic for at least 2 consecutive days - standard bridging practice specifically to cover the early protein C-depletion window

Associations

Protein C/S deficiency, DOACs as an alternative to warfarin (avoiding this specific complication), calciphylaxis (an important differential, particularly in patients with CKD - a separate mechanism of cutaneous vascular calcification/necrosis)

Natural history & complications

Warfarin-induced skin necrosis is a specifically preventable complication when standard heparin/LMWH bridging protocol is correctly followed and maintained for the appropriate duration during warfarin initiation

6 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.

Get premium access